Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).
Quick Stats
Jun 23, 202658.7
AI Score
HOLD0.25
Volume Ratio
Aug 07, 2026
Next Earnings
14
+ve Days (30d)
16
-ve Days (30d)
REGN Stock Summary
Last updated Jun 23, 2026
REGN is currently trading at $617.6, positioned below its 200-day moving average of $697.66, suggesting bearish momentum. The stock has a 52-week range of $507.61 to $821.11.
Technical Analysis: The 50-day moving average stands at $674.3, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 40.524, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.095, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates REGN at 58.7/100 with a HOLD recommendation.
REGN (Regeneron Pharmaceuticals Inc) Indicators
Last updated Jun 23, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 40.524 |
| CMF (20) | -0.095 |
| ROC (10) | 0.543 |
| ADX (14) | 38.65 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -16.849 |
| AROONOSC (14) | 21.429 |
| WILLAMS %R (14) | -56.969 |
| MFI (14) | 44.952 |
REGN Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
REGN Price vs Max Options Open Interest
REGN Max Change In Options Open Interest
REGN Options - Sort by Max open Interest (near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
REGN Daily Out of Money Options - Sort by Max open Interest (near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
REGN Daily In the Money Options - Sort by Max open Interest (near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
REGN Most Active Options by Volume(near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Regeneron Pharmaceuticals Inc is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
REGN Moving Averages Analysis
REGN (Regeneron Pharmaceuticals Inc) Simple Moving Averages
Moving Averages are last updated Jun 23, 2026
| Days | MA |
|---|---|
| 10 | 611.91 |
| 20 | 615.79 |
| 30 | 635.81 |
| 50 | 674.3 |
| 100 | 720.12 |
| 200 | 697.66 |
REGN Fundamental Analysis
| P/E (Forward) | 13.587 |
| P/E (Trailing) | 14.8802 |
| Market Cap ($) | 63.9 billion |
| Earnings/Share ($) | 40.99 |
| Net Proft Margin (%) | 0.2965 |
| Dividend/Share ($) | 3.58 |
| EPS Estimate Current Year ($) | 46.246 |
| EPS Estimate Next Year ($) | 48.1019 |
| WallStreet Target Price ($) | 833.3061 |
| Most Recent Quarter |